Vericel VCEL
NASDAQ VCEL
$40.19 -0.28 (-0.69%)
As of: Sep 4, 2026 · 3:59 PM EDT

Vericel (VCEL) Cash from Operations (2010 - 2026)

Vericel (VCEL) posted Cash from Operations of 16191000.0 for Q2 2026, down 1.17% sequentially from 16383000.0 in Q1 2026, and up 97.11% YoY from 8214000.0 in Q2 2025.

Analysis

Vericel (VCEL) Cash from Operations (2010 - 2026) Analysis & Trends

Vericel has reported Cash from Operations for 17 years, with the latest figure at 16191000.0 in Q2 2026.

  • Quarterly Cash from Operations rose 97.11% year-over-year to 16191000.0 in Q2 2026, while the trailing twelve-month figure through Jun 2026 was 69670000.0 (up 47.48% YoY) and the FY2025 annual result came in at 51910000.0, down 10.75% from the prior year.
  • Cash from Operations declined to 16191000.0 in Q2 2026 per VCEL's latest filing, from 16383000.0 in the prior quarter.
  • Over five years, Cash from Operations peaked at 22242000.0 in Q4 2024 and troughed at 3143000.0 in Q2 2022.
  • A 5-year average of 10869166.67 and a median of 9150000.0 in 2023 frame the typical range for Cash from Operations.
  • The sharpest annual moves came in 2022 and 2023: Cash from Operations slumped 65.62% in 2022, then soared 224.4% in 2023.
  • Over 5 years, Cash from Operations stood at 6975000.0 in 2022, then surged by 44.6% to 10086000.0 in 2023, then surged by 120.52% to 22242000.0 in 2024, then sank by 32.5% to 15014000.0 in 2025, then rose by 7.84% to 16191000.0 in 2026.
  • According to Business Quant data, Cash from Operations over the past three periods registered 16191000.0, 16383000.0, and 15014000.0 for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Operations (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn 1.13 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 813.00 Mn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn -
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn -526.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn - -387.32 Mn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 462.82 Mn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn 326.72 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn - 728.46 Mn
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn -88.83 Mn
10 Vericel 2.05 Bn 1.89 Bn 56.40 Mn 16.19 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 16.19 Mn
Mar 31, 2026 16.38 Mn
Dec 31, 2025 15.01 Mn
Sep 30, 2025 22.08 Mn
Jun 30, 2025 8.21 Mn
Mar 31, 2025 6.60 Mn
Dec 31, 2024 22.24 Mn
Sep 30, 2024 10.18 Mn
Jun 30, 2024 18.54 Mn
Mar 31, 2024 7.20 Mn
Dec 31, 2023 10.09 Mn
Sep 30, 2023 7.17 Mn
Jun 30, 2023 10.20 Mn
Mar 31, 2023 7.86 Mn
Dec 31, 2022 6.98 Mn
Sep 30, 2022 4.10 Mn
Jun 30, 2022 3.14 Mn
Mar 31, 2022 3.47 Mn
Dec 31, 2021 10.55 Mn
Sep 30, 2021 3.63 Mn